Filing Details
- Accession Number:
- 0001140361-14-023225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-27 19:15:11
- Reporting Period:
- 2014-05-22
- Filing Date:
- 2014-05-27
- Accepted Time:
- 2014-05-27 19:15:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 350907 | Thoratec Corp | THOR | Electromedical & Electrotherapeutic Apparatus (3845) | 942340464 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248380 | F Neil Dimick | 6035 Stoneridge Drive Pleasanton CA 94588 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-22 | 2,825 | $32.12 | 42,286 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-23 | 697 | $32.01 | 41,589 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-27 | 636 | $32.43 | 40,953 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares of Common Stock sold pursuant to a Sales Plan established by the Reporting Person on September 11, 2013, which Sales Plan is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act 1934, as amended.
- This transaction was executed in multiple trades in prices ranging from $31.55 to $32.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $31.78 to $32.21. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades in prices ranging from $32.32 to $32.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
